Results 241 to 250 of about 638,968 (308)

Proteome-based molecular subtyping and therapeutic target prediction in cervical cancer. [PDF]

Biomark Res
Yang T, Guo L, Liu D, Hua K, Li C.
europepmc   +1 more source

Skeletal pathologies in extant crocodilians as a window into the paleopathology of fossil archosaurs

The Anatomical Record, EarlyView.
Abstract Crocodilians, together with birds, are the only extant relatives to many extinct archosaur groups, making them highly important for interpreting paleopathological conditions in a phylogenetic disease bracketing model. Despite this, comprehensive data on osteopathologies in crocodilians remain scarce.
Alexis Cornille, Kyla Beguesse, Ewan Wolff, Clemens Zinner, Patrick Asbach, François Clarac, Florian Witzmann   +6 more
wiley   +1 more source

HPV, Cytology, and Cotest Cervical Cancer Screening and the Risk of Precancer.

JAMA Netw Open
Gottschlich A, Smith LW, Hong Q, Dabee S, Gondara L, Cook D, Martin RE, Melnikow J, Peacock S, Proctor L, Stuart G, Franco EL, Krajden M, Ogilvie GS.   +13 more
europepmc   +1 more source

Change of Cervical Cancer Stage at Diagnosis After the COVID-19 Pandemic. [PDF]

Cureus
Tobon-Osornio F, Arellano-Llamas AA, Perales-Flores PM, Torrecilla-Toledo CA, Martínez-Chávez LU, Sandoval-Mejía AL, Hernández-Caballero A, Aboites-Lucero JL.   +7 more
europepmc   +1 more source

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

Arthritis &Rheumatology, EarlyView.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

Analysis of Reactive Oxygen Species-Induced Cellular Damage in Cervical Cancer. [PDF]

Curr Protoc
Chan HCC, Bhoora S, Zhou E, Marais S, Punchoo R.   +4 more
europepmc   +1 more source

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study

Arthritis &Rheumatology, EarlyView.
Objective To evaluate the efficacy and safety of guselkumab, an interleukin‐23p19 subunit inhibitor, in participants with active psoriatic arthritis (PsA) and inadequate response (inadequate efficacy and/or intolerance) to one prior tumor necrosis factor (TNF) inhibitor.
Alexis Ogdie, Joseph F. Merola, Philip J. Mease, Christopher T. Ritchlin, Jose U. Scher, Kimberly Parnell Lafferty, Daphne Chan, Soumya D. Chakravarty, Wayne Langholff, Yanli Wang, Jie Shao, Yevgeniy Krol, Alice B. Gottlieb   +12 more
wiley   +1 more source

Human papillomavirus-encoded microRNAs: key regulators in cervical cancer development. [PDF]

RNA Biol
Bencheikh S, Lemriss H, Souiri A, Akachar J, Laarej K, Ameziane El Hassani R, Lemriss S.   +6 more
europepmc   +1 more source

Cervical Cancer Screening, HPV Vaccination, and Cervical Cancer Elimination.

JAMA Netw Open
Luu XQ, Jun JK, Suh M, Oh JK, Yu SY, Choi KS.   +5 more
europepmc   +1 more source